Mirion Technologies, Inc. Completes Acquisition of Computerized Imaging Reference Systems, Inc.
December 02 2021 - 7:00AM
Business Wire
Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”), a
global provider of detection, measurement, analysis and monitoring
solutions to the medical, nuclear, defense, and research end
markets, today announced that it had completed the acquisition of
Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading
provider of medical imaging and radiation therapy phantoms serving
the medical industry.
CIRS specializes in the design, development and
commercialization of tissue equivalent medical imaging and
radiation therapy phantoms for the radiotherapy and
radio-diagnostic markets. The critical technology of CIRS is used
to:
- Calibrate and test diagnostic imaging and radiation therapy
equipment;
- Measure radiation dose in specific anatomical geometries;
- Maintain critical quality assurance standards; and
- Improve patient outcomes.
On November 11, 2021, Mirion had announced that the Company had
signed a definitive agreement to acquire CIRS for approximately $54
million, and will be integrated into the Company’s Medical
segment.
Forward-Looking Statements This press release contains
forward-looking statements within the meaning of Section 21E of the
Securities Exchange Act of 1934. Words such as “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “hope,”
“intend,” “may,” “might,” “should,” “would,” “will,” “understand”
and similar words are intended to identify forward looking
statements. These forward-looking statements include but are not
limited to, statements regarding the critical technology of CIRS
and the benefits of CIRS’ technology to Mirion and its customers.
There are a significant number of factors that could cause actual
results to differ materially from statements made in this press
release, including the risk that problems may arise in integrating
CIRS’ business and technology and that expected benefits, operating
results and synergies may not develop as anticipated.
Additional risks and uncertainties that could affect the
forward-looking statements in this press release are included under
the captions “Risk Factors” and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” set
forth from time to time in filings and reports we make from time to
time with the Securities and Exchange Commission, including our
Quarterly Report on Form 10-Q filed on November 10, 2021.
You should not rely on these forward-looking statements, as
actual outcomes and results may differ materially from those
contemplated by these forward-looking statements as a result of
such risks and uncertainties. All forward-looking statements in
this press release are based on information available to us as of
the date hereof, and we do not assume any obligation to update the
forward-looking statements provided to reflect events that occur or
circumstances that exist after the date on which they were
made.
About Mirion Mirion Technologies is a leading provider of
detection, measurement, analysis and monitoring solutions to the
nuclear, defense, medical and research end markets. The
organization aims to harness its unrivaled knowledge of ionizing
radiation for the greater good of humanity. Headquartered in
Atlanta (GA – USA), Mirion employs around 2,500 people and operates
in 13 countries. For more information, and for the latest news and
content from Mirion, visit Mirion.com.
About Computerized Imaging Reference Systems, Inc.
Computerized Imaging Reference Systems, Inc. (CIRS) was founded in
1982 by Dr. Elias Zerhouni and is based in Norfolk, VA. CIRS
develops tissue simulation and medical phantom technology for the
radiation therapy and diagnostic imaging markets and has become a
recognized leader in medical quality (QA) solutions. For more
information, visit cirsinc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211202005267/en/
For investor inquiries: Brian Schopfer ir@mirion.com
For media inquiries: Matthew Maddox
mmaddox@mirion.com
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Oct 2023 to Oct 2024